Impaired glucose metabolism in patients with newly diagnosed coronary artery disease

被引：0
|
作者：
Gotsis, A. [1 ]
Bozia, P. [1 ]
Dourtsiou, S. [1 ]
Labrou, A. [1 ]
Papadopoulou, L. [1 ]
Savvopoulou, A. [1 ]
Borghi, L. [1 ]
Theodoridis, D. [1 ]
Karras, S. [1 ]
Panagiotidou, A. [1 ]
机构：
[1] Gen Hosp Komotini, Dept Cardiol, Komotini, Greece
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)81392-9
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
WeP1136
引用
收藏
页码：353 / 354
页数：2
相关论文
共 50 条
  • [1] The effects of hypertension and impaired glucose metabolism in patients with coronary artery disease
    Gotsis, A
    Karakiriou, M
    Bozia, P
    Labrou, A
    Kyrkoudis, A
    Marinos, E
    Borghi, L
    Karagkiozaki, V
    Savvopoulou, A
    Panagiotidou, A
    JOURNAL OF HYPERTENSION, 2004, 22 : S402 - S403
  • [2] Adiponectin concentration in patients with newly diagnosed Type 2 diabetes mellitus and impaired glucose tolerance and coronary artery disease
    Kowalska, I
    Straczkowski, M
    Nikolajuk, A
    Kinalska, I
    DIABETOLOGIA, 2003, 46 : A371 - A372
  • [3] Adiponectin in coronary heart disease and newly diagnosed impaired glucose tolerance
    Ghanbari, Aline Azizi
    Doerr, Rolf
    Spitzer, Stefan
    Stumpf, Juergen
    Britz, Andreas
    Amann-Zalan, Ildiko
    Lodwig, Volker
    Ulm, Bernhard
    Schnell, Oliver
    Lohmann, Tobias
    DIABETES & VASCULAR DISEASE RESEARCH, 2013, 10 (05): : 452 - 458
  • [4] Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and impaired glucose metabolism
    Sa, D.
    Dos Reis, R. Palma
    Santos, M.
    Temtem, M.
    Sousa, A. C.
    Henriques, E.
    Rodrigues, M.
    Freitas, S.
    Borges, S.
    Ornelas, I.
    Drumond, A.
    Mendonca, M. I.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1153 - 1153
  • [5] Relation between impaired glucose metabolism and coronary artery disease
    Gotsis, AK
    Bozia, PI
    Karakiriou, MK
    Labrou, AD
    Marinos, EE
    Karagkiozaki, VC
    Papagianni, AE
    Borghi, LF
    Haritos, SD
    Panagiotidou, AE
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 122 - 122
  • [6] Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease
    Sugiyama, Seigo
    Ogawa, Hisao
    CIRCULATION, 2006, 114 (18) : 849 - 849
  • [7] Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease
    Sugiyama, Seigo
    Fukushima, Hironobu
    Kugiyama, Kiyotaka
    Maruyoshi, Hidetomo
    Kojima, Sunao
    Funahashi, Tohru
    Sakamoto, Tomohiro
    Horibata, Yoko
    Watanabe, Keisuke
    Koga, Hidenobu
    Sugamura, Koichi
    Otsuka, Fumiyuki
    Shimomura, Iichirou
    Ogawa, Hisao
    ATHEROSCLEROSIS, 2007, 194 (02) : E43 - E51
  • [8] Implications of abnormal glucose metabolism in patients with coronary artery disease
    Anselmino, Matteo
    Wallander, Marit
    Norhammar, Anna
    Mellbin, Linda
    Ryden, Lars
    DIABETES & VASCULAR DISEASE RESEARCH, 2008, 5 (04): : 285 - 290
  • [9] Plaque Characteristics in Coronary Artery Disease Patients with Impaired Glucose Tolerance
    Suzuki, Keishi
    Takano, Hitoshi
    Kubota, Yoshiaki
    Inui, Keisuke
    Nakamura, Shunichi
    Tokita, Yukichi
    Kato, Koji
    Asai, Kuniya
    Shimizu, Wataru
    PLOS ONE, 2016, 11 (12):
  • [10] Analysis of Patients With Coronary Heart Disease Combined With Impaired Glucose Metabolism
    高志平
    黎励文
    周颖玲
    董豪坚
    SouthChinaJournalofCardiology, 2009, 10 (02) : 49 - 52
12345